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Without Dementia: A Review
Riccardo Manca †, Matteo De Marco † and Annalena Venneri*
Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom
Background: The sudden and drastic changes due to the Coronavirus Disease
19 (COVID-19) pandemic have impacted people’s physical and mental health.
Clinically-vulnerable older people are more susceptible to severe effects either directly
by the COVID-19 infection or indirectly due to stringent social isolation measures.
Social isolation and loneliness negatively impact mental health in older adults and may
predispose to cognitive decline. People with cognitive impairments may also be at high
risk of worsening cognitive and mental health due to the current pandemic. This review
provides a summary of the recent literature on the consequences of COVID-19, due to
either viral infection or social isolation, on neuropsychiatric symptoms in older adults with
and without dementia.
Methods: A search was conducted in PubMed and Web of Science to identify all
relevant papers published up to the 7th July 2020. Two independent assessors screened
and selected the papers suitable for inclusion. Additional suitable papers not detected
by literature search were manually added.
Results: Fifteen articles were included: 8 focussed on the psychiatric symptoms
caused by the COVID-19 infection and 7 investigated the impact of social isolation
on older adults’ neuropsychiatric symptoms. Four studies included older adults without
dementia and 11 included patients with cognitive impairment mainly due to Alzheimer’s
disease. All studies found that different neuropsychiatric symptoms emerged and/or
worsened in older adults with and without dementia. These changes were observed as
the consequence of both COVID-19 infection and of the enforced prolonged conditions
of social isolation. Cases were reported of viral infection manifesting with delirium at onset
in the absence of other symptoms. Delirium, agitation and apathy were the symptoms
most commonly detected, especially in people with dementia.
Conclusion: The available evidence suggests that the COVID-19 pandemic has a wide
negative impact on the mental well-being of older adults with and without dementia.
Manca et al. Ageing and COVID-19 Neuropsychiatric Complications
Viral infection and the consequent social isolation to limit its spreading have a range of
neuropsychiatric consequences. Larger and more robustly designed studies are needed
to clarify such effects and to assess the long-term implications for the mental health of
older adults, and to test possible mitigating strategies.
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INTRODUCTION
The current pandemic of Coronavirus Disease 2019 (COVID-19)
has brought abrupt and pervasive changes in our lives that
go beyond the infection itself and its consequences on the
physical and mental health of those infected. In fact, of
equal relevance are the psycho-social consequences generated
by the measures put in place worldwide by governments
to limit the spreading of COVID-19 and by the traumatic
course of events experienced by all those directly involved
in this crisis. The biologically-mediated effects of COVID-19
infection have been shown to be multifaceted. Among the
many clinical manifestations a variety of neuropsychiatric
symptoms (1) and delirium (2) have been observed in patients
with severe COVID-19 infection, even in the absence of
any other symptoms/signs. Likewise, the psycho-social impact
of this pandemic on the mental health of the general
population, as well as of frontline workers and people
with pre-existing psychiatric conditions, has been extensively
documented (3).
Since the beginning of the pandemic, particular concerns
have been raised to protect the most clinically vulnerable
people in our society, including older adults (i.e., above 60
years old). Analyses carried out using clinical data accumulated
over the first half of 2020 and prognostic prediction models
clearly show that older adults are particularly vulnerable to
COVID-19 infection (4), especially if they are affected by
comorbidities such as Alzheimer’s disease (AD) (5). The mental
well-being of people with dementia who are socially isolating
is also considered to be at extremely high risk and a thorough
clinical management of this population is regarded as a top
priority, especially for those living in care homes, since up to
98% of them present with neuropsychiatric symptoms (6, 7).
In fact, a significant association between social isolation and
both mental health (8) and levels of cognitive abilities (9)
has already been observed in older adults and appears to be
mediated by loneliness, i.e., the subjective perception of social
isolation. Moreover, greater loneliness has also been found to be
significantly associated with reduced brain volume in areas in
the left medial temporal lobe involved in memory and harshly
affected by AD (10). Consistently, two recent meta-analyses
suggested that both poor social engagement/isolation (e.g.,
living alone, having a limited social network, low frequency of
social contact, or inadequate social support) (11) and loneliness
(12) may significantly increase the likelihood of developing
dementia. Therefore, a suddenly and drastically impoverished
social environment may be particularly detrimental to older
people, and may contribute to worsen neurological ageing and
neurodegeneration-related processes.
However, many of the questions sparked around the potential
detrimental effects of the current pandemic on neuropsychiatric
manifestations in older adults still remain unanswered. To
address this theoretical gap, the scientific community has been
very active in the timely attempt to collect clinical data from the
populations of interest. As a result of such hectic efforts, however,
the relevant findings are quite scattered at time of writing (July
2020). For this reason, the aim of this review was to summarise
the initial wealth of knowledge provided by papers published in
the first half of 2020 that reported original data on the effects
of the COVID-19 pandemic, both biological (i.e., in individuals
who have contracted the virus) and psycho-social (i.e., due to
social isolation), on neuropsychiatric symptoms (i.e., behavioural
and psychological issues related to the realm of mental health) in
older adults with and without dementia. To provide an overview
of these two distinct, but inter-connected theoretical aspects, we
have included a graphical framework of reference (Figure 1).
METHODS
A systematic literature search was carried out in two online
databases, PubMed and Web of Science, to identify equally
studies within the remit of medicine and social sciences. A series
of keywords regarding the three main factors investigated were
used in order to capture all relevant papers: (1) “COVID-19”
and “COVID19” for the COVID-19 infection; (2) “dementia,”
“mild cognitive impairment,” “neurodegeneration,” “Alzheimer’s
disease,” “older adults,” “ageing” and “aging” for the populations
of interest; (3) “neuropsychiatric,” “psychiatric,” “behavioural,”
“behavioral,” “neurobehavioural,” “neurobehavioral” and
“delirium” for the specific symptoms. No date-of-publication
interval time limits were set for the literature search, but only
papers published up to 7th July 2020 (last day of literature
search) were eventually included. All publications found were
initially screened to identify papers reporting original data,
with no restrictions regarding the type of article (e.g., letters
and commentaries were included, as long as they presented
novel data on the topic of interest). The abstracts of these were
reviewed by two independent assessors (MDM and RM) to
select all relevant papers to be retained. The exclusion criteria
were the following: (1) manuscripts not in English, (2) studies
on populations other than those of interest (e.g., children,
adolescents, young/middle-aged adults, medical personnel,
or general samples of participants not including a distinctive
group of older adults), (3) studies focussed on disease and
treatment mechanisms, (4) studies investigating other clinical or
social/psycho-social aspects of no relevance to this review and
(5) non-clinical studies exploring subsidiary topics (e.g., health
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FIGURE 1 | Schematic representation of the theoretical framework whereby the COVID-19 pandemic would be associated to the onset/worsening of behavioural and
psychiatric symptoms.
economics, standards of hygiene or the impact of COVID-19 on
insurance companies). A third assessor (AV) helped resolving
any disagreement on publications to be included. Additional
papers with novel data relevant to this review that were not
detected by the literature search but identified through other
sources (i.e., references and key journals) were also screened and
manually added.
RESULTS
The literature search across the two databases resulted in
344 entries. Of these, 127 were repetitions and were thus
discarded. The remaining 217 manuscripts were screened to
separate those including original data (i.e., observational studies,
case series, single-case descriptions) from those not including
original data. This led to 120 manuscripts being retained for
further consideration, 7 of which were immediately discarded
for not being published in English. It was at this point that
each abstract (or, in the case of manuscripts such as letters
and commentaries, the entire manuscript) was consulted by
the two independent assessors. During the shortlisting process
(illustrated in Figure 2), 14manuscripts described studies carried
out on adolescents or young-middle aged adults, and in other
13 manuscripts the age range included younger and older adults
without a specific sub-sample of older adults only. Fourteen
additional manuscripts were discarded because focussed on the
study of medical personnel. Of the 72 remaining manuscripts,
10 focussed on disease mechanisms, 20 addressed clinical
aspects of no interest for the current review while another
4 dealt with tangential aspects of the pandemic. Finally, 26
of the remaining manuscripts were discarded because their
experimental hypothesis was about social or socio-psychological
aspects of no direct relevance for this review. The remaining
12 manuscripts were included in the process of review.
Three additional manuscripts of pertinence were found and
manually added to this pool of publications, for a total of 15
manuscripts. These are reported in Table 1 together with their
main methodological aspects and outcome.
Individuals With Acute COVID-19 Infection
Eight papers focussed on the neuropsychiatric manifestations
of COVID-19 infection, 2 carried out in older adults without
dementia (13, 14) and 6 in older adults living with dementia,
mostly due to AD aetiology (15–20). Study designs included:
one single case (13), three case series (16, 19, 20), two single-
centre retrospective analyses of hospital admissions (17, 18) and
two multi-centre investigations, one retrospective analysis of
COVID-19 cases (15) and one surveillance clinical repository
purposely created (14).
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FIGURE 2 | Manuscript selection procedures adopted in this study.
Studies on Older Adults Without Dementia
Alkeridy et al. (13) described the single case of a 73-year-old man
without dementia who resulted positive to testing for COVID-19.
The authors observed that this patient presented exclusively with
delirium at onset, in the absence of the most common symptoms
observed in people infected with COVID-19 (i.e., high fever,
dry cough and tiredness), as reported by the outline published
by the World Health Organisation (https://www.who.int/health-
topics/coronavirus#tab=tab_3). A multi-centre study including
125 patients (most of whom aged 60 or above) with COVID-19
and a complete clinical assessment, found that, at onset, 31.2%
presented with, among other symptoms, altered mental status,
i.e., acute alteration in personality, behaviour, cognition, or
consciousness (14). As many as 59% of these patients met criteria
for psychiatric diagnoses, with the great majority being new cases
of psychoses, neurocognitive disorders, and affective disorders.
In both studies, assessment of neuropsychiatric symptoms was
based on a clinician’s judgment, and no use of standardised tools
was reported.
Studies Including Older Adults With Dementia
Three papers described case series reporting a total of 8 patients
with dementia due to different underlying conditions: two
unspecified and one with dementia with Lewy Bodies (16); 3 cases
of AD (19, 20); one case of frontotemporal lobar degeneration
and one of vascular dementia (20), respectively. All patients
were aged 70 or above, 5 were women and 3 men. In all
cases, the neuropsychiatric manifestations of COVID-19 were
clinician-reported. At hospitalisation, all patients presented with
Frontiers in Psychiatry | www.frontiersin.org 4 October 2020 | Volume 11 | Article 585540
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TABLE 1 | Characteristics and summary of the results of the studies included.
Article COVID-19
effects
Population
diagnosis
Methodology Sample size Age (years) Neuropsychiatric
symptoms
Assessment
tools
Results
INDIVIDUALS WITH ACUTE COVID-19 INFECTION—STUDIES ON OLDER ADULTS WITHOUT DEMENTIA
Alkeridy
et al. (13)
Effects of
infection
Older adults
without
dementia
Case description 1 73-year-old man Delirium Clinical judgment The patient presented with delirium as onset symptom of
COVID-19 infection.
Varatharaj
et al. (14)
Effects of
infection
Adults without
dementia
Multi-centre clinical
repository
153 (only 125 with
complete
assessments)
61–70 (n = 23),
71–80 (n = 31),
81–90 (n = 23),
≥ 91 (n = 5)
Altered mental
status
Clinical judgment Altered mental status was observed in 31.2% of the
patients with complete assessments: 41% of these had
encephalopathy/encephalitis, while 59% met the criteria
for different psychiatric diagnoses (91.3% of which were
new). The most common disorders were: psychoses,
neurocognitive disorders, and affective disorders.
INDIVIDUALS WITH ACUTE COVID-19 INFECTION—STUDIES INCLUDING OLDER ADULTS WITH DEMENTIA
Annweiler
et al. (15)
Effects of
infection
Older adults with
and without
MND above 70
years of age
Multi-centre
retrospective
description of last 10
patients per institution
353 (no MND = 219,
MND = 134)
84.7 (±7.0)* Delirium and
altered
consciousness
Clinical judgment Older adults with compared to those without MND were
more likely to present with delirium, both hypoactive
(27.6 vs. 11.4%) and overactive (14.9 vs. 5.5%), and
altered consciousness (17.2 vs. 6.4%). Rates of delirium
and loss of consciousness were similar between
individuals aged 70–80 and over 80.
Beach et al.
(16)
Effects of
infection
MND
(unspecified
cause) and DLB
Case series
description
3 (an additional case
with COVID-19
infection and
schizophrenia also
included)
70-year-old
man,
76-year-old
man, and
87-year-old
woman
Delirium Clinical judgment Two cases of MND, one with behavioural and psychotic
problems and one with depression with psychotic
features, and one case of DLB presented with delirium
and agitation during hospitalisation.
Bianchetti
et al. (17)
Effects of
infection
Dementia
(unspecified
cause)
Retrospective analysis
of regional acute
hospital admissions
627 (no dementia =
545, dementia = 82)
82.6 (± 5.3), IQR
80–86
(dementia)
Behavioural
symptoms and
delirium
Clinical judgement At onset: most common symptom in people with
dementia was delirium (67%), especially hypoactive
(50%); behavioural symptoms were present in 11% of
patients
Lovell et al.
(18)
Effects of
infection
Older adults with
and without
dementia
(unspecified
cause)
Retrospective analysis
of case series
101 (dementia = 31) 82 (72–89)† Agitation,
drowsiness, and
delirium
Clinical judgment At time of referral to palliative care unit, dementia was the
third most common comorbidity (30.7%). Overall, 42.5%
of patients presented with agitation, 35.6% with
drowsiness, and 23.8% with delirium.
Sinvani
et al. (19)
Effects of
infection
Advanced
dementia due to
AD
Case series
description
1 (other two severe
cases of older adults
with COVID-19
infection were also
included)
76-year-old
woman
Behavioural
symptoms
Clinical judgment After a few days of hospitalisation, the patient showed
agitation and violent behavioural changes that, however,
resolved with personalised care.
Ward et al.
(20)
Effects of
infection
AD, FTD, VD Case series
description
4 (2 AD; 1 FTD, 1 VD) 83.3 (± 10.2)*, 3
women, and 1
man
Altered mental
status
Clinical judgment All cases presented at onset with delirium and agitation.
Delirium was particularly severe in 2 cases and
associated with loss of appetite and disorientation.
(Continued)
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TABLE 1 | Continued
Article COVID-19
effects
Population
diagnosis
Methodology Sample size Age (years) Neuropsychiatric
symptoms
Assessment
tools
Results
INDIVIDUALS WITHOUT COVID-19 INFECTION IN CONDITIONS OF INCREASED SOCIAL ISOLATION—STUDIES ON OLDER ADULTS WITHOUT DEMENTIA
Emerson
et al. (21)
Effects due to
social isolation
Older adults
without
dementia above
60 years of age
Online survey 833 60–70 (n = 523),
71+ (n = 310)
Overall mental
health and stress
Web-based
survey,
self-reported
assessment
No differences in self-rated mental health were found
between older adults aged 60–70 and 70+. However,
the younger group reported having experienced higher
levels of stress than the older group after social isolation
enforcement.
Shrira et al.
(22)
Effects due to
social isolation
Older adults
without
dementia
Online questionnaire
completed by older
adults
277 69.58 (± 6.72)*,
range 60–92
Anxiety,
depression, and
peritraumatic
distress
Web-based
GAD-7, PHQ-9,
and PDI
Loneliness due to social isolation was positively
associated with levels of anxiety, depression and
peritraumatic distress, especially among individuals
feeling older than their age.
INDIVIDUALS WITHOUT COVID-19 INFECTION IN CONDITIONS OF INCREASED SOCIAL ISOLATION—STUDIES INCLUDING OLDER ADULTS WITH DEMENTIA
Boutoleau-
Bretonnière
et al. (23)
Effects due to
social isolation
Dementia due to
probable AD
Telephonic
questionnaires
administered to a
caregiver
38 71.89 (± 8.24)* NPS NPI-Q Caregiver-reported worsening of NPS in 26.3% of
patients. Duration of confinement correlated with NPI-Q
score and caregivers’ distress in patients who showed
worsening of NPS.
Canevelli
et al. (24)
Effects due to
social isolation
Dementia, MCI,
SCD
(unspecified
cause)
Telephonic survey
administered to
patients or caregivers
139 (dementia = 96,
MCI/SCD = 43)
80.5 (76–85)‡
(dementia); 73
(65.5–77.5)‡
(MCI/SCD)
NPS Patient- and
caregiver-
reported
changes
Overall, NPS improved in only a few patients (2.1% of
demented and 7% of MCI/SCD), while NPS worsened in
the majority of patients (57.3 and 48.8%, respectively),
especially agitation, apathy, depression and irritability.
Fahed et al.
(25)
Effects due to
social isolation
Dementia due to
AD
Case series
description
1 (a second case of a
patient with
narcissistic personality
disorder was also
included)
83-year-old man Behavioural
symptoms
Clinical judgment The patient was admitted to an inpatient psychiatric unit
during COVID-19 pandemic because of severe agitation.
During hospital stay he experienced mood lability,
agitation and violent behaviours. All symptoms worsened
after he was room isolated because suspected to have
COVID-19. All interventions had little or no effect.
Lara et al.
(26)
Effects due to
social isolation
Dementia due to
mild AD and
amnestic MCI
Telephonic
questionnaires
administered to a
caregiver
40 (AD = 20, MCI =
20)
77.4 (± 5.25)* NPS NPI General worsening of NPI scores was observed after 5
weeks of confinement in agitation, apathy and aberrant
motor behaviour symptoms particularly. Changes were
similar between patient groups. Apathy and anxiety
worsened especially in the MCI group; while apathy,
agitation, and aberrant motor behaviours worsened
mainly in the AD group.
Padala et al.
(27)
Effects due to
social isolation
Dementia due to
AD
Case description 1 81-year-old man NPS NPI After restrictions were enforced for relatives’ visits to
people in nursing homes, this patient with AD showed
increased depression, anxiety, apathy, irritability, difficulty
sleeping, and general restlessness. Symptoms improved
after video calls with relative were arranged.
*mean (± Standard deviation).
†
median (Range).
‡
mean (Interquartile range).
AD, Alzheimer’s Disease; DLB, Dementia with Lewy Bodies; FTD, Frontotemporal Dementia; GAD-7, 7-item Generalized Anxiety Disorder scale; IQR, Interquartile range; MCI, Mild Cognitive Impairment; MND, Major Neurocognitive
disorder; NPI, Neuropsychiatric Inventory; NPI-Q, Neuropsychiatric Inventory Questionnaire; NPS, Neuropsychiatric Symptoms; PDI, 13-item Peritraumatic Distress Inventory; PHQ-9, 9-item Patient Health Questionnaire; SCD, Subjective
Cognitive Decline; VD, Vascular Dementia.
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agitation and 7 out of 8 with delirium. In 2 cases of severe
delirium, disorientation and loss of appetite were also reported
(20). At least in one case, behavioural disturbance subsided with
personalised care (19).
Retrospective investigations of large cohorts of hospitalised
patients found that the most common symptoms in those with
dementia were delirium, especially in its hypoactive variant,
and altered consciousness (15, 17). Similarly, Lovell et al. (18)
found that, among the more severe cases of COVID-19 infection
admitted to palliative care units, about 30% were people with
dementia and many presented with a range of neuropsychiatric
symptoms, such as agitation, and delirium.
Individuals Without COVID-19 Infection in
Conditions of Increased Social Isolation
Seven studies focussed on investigating the impact that
social isolation due to COVID-19-related restrictions had on
neuropsychiatric symptoms of older adults with (23–27) and
without dementia (21, 22). Only one single case (27) and one
case series (25) were described, while all the other studies
used surveys/questionnaires implemented either via online (21,
22) or telephonic (23, 24, 26) administration. The majority
of these studies included standardised tools to assess the
presence and severity of neuropsychiatric symptoms, mostly the
Neuropsychiatric Inventory (NPI) (23, 26, 27).
Studies on Older Adults Without Dementia
In a large online survey including 833 healthy older adults
(aged ≥ 60) socially isolating during the COVID-19 pandemic,
Emerson et al. (21) found no differences in self-rated mental
health between older adults aged 60–70 and those aged above 70.
However, the younger group reported higher levels of stress than
the older group. Shrira et al. (22) observed a significant positive
association between loneliness due to social isolation and levels
of anxiety, depression, and peri-traumatic distress in older adults.
This association was particularly strong for those individuals who
felt older than their actual demographic age.
Studies Including Older Adults With Dementia
Emergence and worsening of neuropsychiatric symptoms were
described in two patients with dementia due to AD after
enforcement of social isolation measures. An 83-year-old man
was hospitalised due to severe agitation that worsened after he
was isolated to his room because suspected to have COVID-
19, with little or no relief gained from either pharmacological
or non-pharmacological interventions (25). An 81-year-old man,
resident in a nursing home, experienced increasing depression,
anxiety, apathy, irritability, difficulty sleeping, and general
restlessness after his relative’s visits had been suspended. All
symptoms improved after video calls with his daughter were
arranged (27).
In a telephone survey, caregivers of people with
cognitive impairment reported mainly worsening of patients’
neuropsychiatric symptoms, both when the underlying clinical
diagnosis was subjective/mild cognitive impairment (48.8%)
and dementia (57.3%), while only a small proportion noticed
amelioration of symptoms (24). Greater impacts were especially
observed for agitation, apathy, depression, and irritability.
Similarly, negative changes in neuropsychiatric symptoms
resulting in high NPI scores were reported by two studies: one
found symptoms worsening in patients with more compromised
cognitive status prior to social isolation and a direct correlation
between length of social isolation and both severity of symptoms
and caregivers’ distress (23); and Lara et al. (26) observed that
comparable changes, especially in apathy, occurred in both
patients with mild cognitive impairment, and dementia due
to AD.
DISCUSSION
The COVID-19 pandemic has taken the world by storm,
inducing an unforeseen course of events that has had a significant
impact on our lives. Aside from the medical emergency
constituted by the actual viral infection, the diffusion of the
virus throughout the world has snowballed into a series of
substantial changes to the way we are now compelled to conceive
a wide number of aspects of life such as healthcare, employment,
financial resources, social interactions, welfare and even simple
routine tasks that prior to this pandemic could be taken for
granted. This has been a radical turn of events with which
societies are coming to terms and, arguably, it will not be an
easy task. For this reason, the advent of the pandemic has the
potential to act as a major trigger for the onset or exacerbation
of certain detrimental psychological traits that in turn may
lead to behavioural/psychiatric symptoms of clinical concern.
In this context, older people (i.e., older than 60) and people
with dementia are among the segments of the population most
susceptible to the detrimental effects of COVID-19. On one hand
they are clinically vulnerable to the viral infection, on the other
hand they are at risk of suffering from the negative consequences
of reduced social interactions (Figure 1).
To shed light on this issue, in this review we searched the
scientific literature in the attempt of putting together research
findings and case descriptions on the topic published over the
first half of 2020, focussing on behavioural and psychiatric
symptoms, but giving equal emphasis to both “mechanistic”
and “reactive” avenues of interference with normal psychological
well-being in people undergoing normal or neurodegenerative
processes of ageing.
Neuropsychiatric Symptoms in People
Who Have Contracted COVID-19
Societies regularly see annual waves of viral infections during
the colder part of the year [e.g., Vestergaard et al. (28)].
While yearly influenza presents itself as a serious yet, in a
sense, “canonical” respiratory family of viruses, it has been
long established that influenza-associated hospital admissions
might present with mental disturbances of psychotic nature
(29). Delirium, in particular, is often seen in clinical settings
in concomitance with acute hospitalisation and infection.
Likewise, a non-negligible amount of clinical evidence has
been collected during the current emergency that suggests
that COVID-19 may also affect the central nervous system
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to a significant extent. The evidence we have reviewed in
the current manuscript is limited to a small number of
studies that converge towards delirium being the most common
behavioural symptom recorded at the peak of the infection,
and even at onset, in the absence of any other symptoms
(13), especially in patients with dementia (17). A substantial
proportion of infected patients also experienced mental health
problems sufficiently severe to meet criteria for a variety of new
psychiatric diagnoses, as well as neurocognitive syndromes, these
latter potentially unveiling ongoing latent neurodegenerative
processes (14). Particularly affected were people with dementia,
who presented often with agitation (16, 18–20) and altered
consciousness (15, 18). It is important to remark that these
findings were collected in clinical environments that, during
the acute phase of the crisis, hosted exclusively severe cases
in need of hospitalisation. As a consequence, it still remains
undetermined whether milder infections may mechanistically
lead to the presence of these or other psychiatric symptoms.
Transient agitation in the acute care setting may occur even
in an individual who does not have a diagnosis of cognitive
impairment or psychiatric disorders, and might be due to a
concatenation of neurological and biochemical factors, including
an underlying infection, hypoxia, and medication side effects
(30). Delirium, instead, is a state of confusion in which a sudden
decline in attentional levels and cognitive resources is observed,
and is typically seen in hospitalised patients. The occurrence
of delirium is determined by a number of predisposing
variables (the baseline vulnerability of the individual) as well as
precipitating factors introduced during the hospital stay (31).
It is well-known that the COVID-19 patients at highest risk
of complications are those who show particular frailty (e.g.,
those who have co-occurring medical conditions). Likewise,
major precipitating factors for delirium are “more than three
medications added” and “use of bladder catheter” (31), that
are a normal occurrence in the hospitalisation of the most
severe cases. In summary, it is unfortunate that the frailest
who require admission to an intensive care unit are also
the more predisposed to developing delirium, and that the
routines associated with hospitalisation provide a further hit
that might exacerbate their profile. Meanwhile, the current
acute neurological and biochemical changes increase the risk
of agitation.
Aside from the manifestations recorded in the acute setting,
it is possible that behavioural and psychiatric complications
might also appear in the long run, in a chronic form (32).
Although there still appears to be a paucity of neuropathological
research (33), a study carried out on the brains of 18 adults
between the ages of 53 and 75 fallen victim to the virus
revealed neither CT-informed macrostructural abnormalities,
nor microstructural damage ascribable to the virus, but only
mild hypoxia-related modifications with, importantly, limited
evidence of viral presence in the brain (34). Incoherently with
these findings, however, structural magnetic resonance imaging
of 30 in vivo severe acute cases revealed multifocal subcortical
FLAIR and diffusion-weighted signal changes, compatible with
oedema, particularly in the mediotemporal lobe, with an
aetiological role played by haemorrhagic lesions as well (35).
Similarly, a young adult hospitalised because of COVID-19-
induced meningitis was described to have hyperintense FLAIR
signal in the right hippocampus (36). While these scant pieces
of evidence are extremely important to lay the foundations for
hypotheses in support of the mechanistic causes of psychiatric
and behavioural symptoms in COVID-19, it is too soon to
establish a definite theoretical framework and define mechanistic
models at the basis of chronic neurological and psychiatric
symptoms. Although any mechanistic hypothesis would be, at
this stage, speculative, it is of central importance to shed light
on the map of regional brain damage caused by the virus,
because the topography of network dysfunction may account
for the onset of chronic behavioural symptoms. A number of
studies has shown that the presence of psychiatric symptoms in
patients with AD is associated with alterations of brain circuitry
(37–39). If COVID-19 infection damages the neural tissue, it
might result into an impoverishment of the neural pathways that
support normal psychological functioning and could lead to the
onset of cognitive and/or psychiatric dysfunction. Future studies
investigating the long-term consequences of COVID-19 on brain
function and psychiatric well-being will have the opportunity
to address this specific theoretical issue. Moreover, a number
of adults who have experienced a particularly severe acute
disease might go on developing post-traumatic stress disorder
symptoms (1) that would increase the burden on the “reactive”
symptomatological profile. In summary, while the presence of
delirium and agitation during the acute phase of the infection
may be due to a more general neuroinflammatory response, more
specific neural mechanisms might underlie the future presence of
chronic psychiatric symptoms.
Neuropsychiatric Symptoms in People in
Social Isolation Due to COVID-19
Pandemic
The studies here reviewed also highlight how healthy older adults
forced to isolate socially reported high levels of stress (21),
anxiety and depression that seem to be particularly associated
with loneliness (22). Similarly, worsening or emergence of
new neuropsychiatric symptoms was found in a substantial
proportion (about 25–60%) of patients with cognitive decline as
a result of social isolation (23, 24), although changes in symptom
severity were found to be similar between patients with mild
cognitive impairment and dementia (26). However, behavioural
disturbances observed in some patients either hospitalised (25) or
resident in nursing homes (27) appeared to be particularly severe
and challenging to manage.
Most of these studies included assessment of neuropsychiatric
symptoms by means of standardised tools (e.g., the NPI)
compared to those carried out on people affected by COVID-19
that relied on clinical judgment. This is likely to be due to
the fact that studies on socially-isolating older adults were
conducted remotely, by recruiting people with no COVID-19
infection mostly living at home. Hence, these samples did not
necessarily require clinical assessment of acute symptoms. In
general, simple and exploratory designs were used, mainly in
the form of online/telephone surveys, but control groups and
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pre-lockdown baseline data were not included, thus preventing
definite conclusions on the strength of the recorded changes.
Nonetheless, these publications suggest, overall, that conditions
of social isolation led to exacerbation or manifestation of a
variety of neuropsychiatric symptoms in cognitively healthy
older adults (especially stress, mood and anxiety) and those
with dementia (mainly agitation and apathy). These reports
also provide interesting clues on which social factors might
affect both trajectories of cognitive and mental health decline,
which appear to be tightly interlinked. Indeed, the presence
of neuropsychiatric symptoms is associated with more severe
progression of cognitive decline in older adults with (40) and
without cognitive impairments (41). Moreover, one of the studies
in this review found that patients with AD whose caregivers
reported to have experienced worsening of neuropsychiatric
symptoms presented with significantly lower global cognitive
status before social isolation enforcement (23).
However, a series of variables which can potentially mitigate
decline in cognitive and neuropsychiatric symptoms in older
adults were not taken into consideration by any of these studies.
For instance, the number of people living in the household or the
width of the social network in contact with them, e.g., neighbours
or online/telephone contacts with friend and relatives. It has
long been established that older adults participating in larger
social networks appear to show lower rates of dementia (42).
Indeed, social network size was found to be positively associated
with maintenance of cognitive performance within the normal
range over a longer period of time, thus postponing dementia
onset independently of APOE status (43). Biomarkers associated
with dysfunctional neural processes and AD have also been
found to be modulated by patients’ social context. Higher levels
of serum brain-derived neurotrophic factor (involved, among
other functions, in synaptogenesis) have been suggested to play a
mediating role between emotional support gained through social
engagement and risk of dementia (44). Moreover, patients with
AD and larger social networks appeared to retain better cognitive
performance even in the presence of high levels of AD pathology,
i.e., load of brain amyloid plaques, assessed post-mortem (45).
Although the governmental instructions provided to older
adults objectively steer towards increased isolation, the extent
to which this translates into a psychological sense of loneliness
may vary. In fact, the association between social isolation and
mental health decline may be particularly mediated by subjective
perceptions: Shankar et al. (46) observed that both loneliness
and social isolation are significantly associated with cognitive
decline over 4 years among older adults and several studies have
suggested that the number of close relationships, poor social
engagement/isolation and loneliness may significantly increase
the likelihood of developing dementia (11, 12, 47). Similarly,
older adults who experience both social isolation and loneliness
have been found to report poorer health quality, with worse
depressive symptoms and a higher number of comorbidities
(8, 48–50). In fact, one study included in this review found
that the relationship between loneliness and mental health was
stronger in those who reported to feel older than their actual
age (22).
These findings lead to the suggestion that higher social
engagement and support experienced both before and during
lockdown due to the COVID-19 pandemic might have had a
protective/mitigating role by contributing to cognitive (51) and
affective reserve (52). During the past few months we have
witnessed a widespread mobilisation of people volunteering to
offer support to the more vulnerable individuals in our societies
and contributing to reduce social isolation (53). It is probably due
to such fast society-wide changes that many older adults also felt
to be part of a common effort to limit the spreading of COVID-19
and, as a consequence, experienced less loneliness despite an
initial increase in the first phase of lockdown (54). However,
it cannot be ruled out that protracted social isolation and/or
loneliness might have also affected a range of biological processes
(linked to neural dysfunction) that could have contributed to the
manifestation of neuropsychiatric symptoms in older adults (55).
This review has highlighted and summarised preliminary
findings available at time of writing on the effects that the
current COVID-19 pandemic has on mental health of older
adults. All the studies included were published in the past few
months in a rapid response to the demand to obtain much
needed insights on this dramatic situation. Negative effects of
both viral infection and social isolation have been reported
in older adults with and without dementia. These must be
taken into account in order to overcome the challenges related
to the delivery of effective care strategies for people with
dementia in the last phases and after the end of this pandemic.
Future studies in larger cohorts, with more robust designs
and theory-grounded will be needed to gain more knowledge
about the short-term and long-term biological and psycho-social
effects of the COVID-19 pandemic on mental health of specific
vulnerable populations of older adults, e.g., people with non-
AD dementias that may present with more severe behavioural
problems (56, 57), and to ascertain the biological and psycho-
social mechanisms that may explain these findings, as well as the
possible risk/protective factors.
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